| scholarly article | Q13442814 |
| P50 | author | Bruce L. Miller | Q56825815 |
| P2093 | author name string | Salvatore Spina | |
| Nicholas T Olney | |||
| P2860 | cites work | Frontotemporal dementia | Q73174314 |
| A protein factor essential for microtubule assembly | Q22010837 | ||
| Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia | Q24309521 | ||
| Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia | Q24323876 | ||
| Classification of primary progressive aphasia and its variants | Q24594803 | ||
| Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia | Q24598142 | ||
| Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia | Q24600027 | ||
| Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease | Q24628685 | ||
| Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72 | Q24630288 | ||
| Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics | Q24630362 | ||
| A harmonized classification system for FTLD-TDP pathology | Q24630756 | ||
| Exome sequencing reveals VCP mutations as a cause of familial ALS | Q24631513 | ||
| Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS | Q24633692 | ||
| Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion | Q24633898 | ||
| A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD | Q24634583 | ||
| A new subtype of frontotemporal lobar degeneration with FUS pathology | Q24647697 | ||
| Cognition and anatomy in three variants of primary progressive aphasia | Q24650108 | ||
| The behavioural variant frontotemporal dementia (bvFTD) syndrome in psychiatry | Q26799091 | ||
| The epidemiology of frontotemporal dementia | Q26823243 | ||
| Potential mechanisms of progranulin-deficient FTLD | Q26863702 | ||
| Neurodegenerative diseases: expanding the prion concept | Q27011744 | ||
| Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging | Q27020981 | ||
| Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis | Q28131672 | ||
| Primary progressive aphasia | Q28213380 | ||
| Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges | Q28235853 | ||
| Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis | Q28236796 | ||
| Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6 | Q28236805 | ||
| Clinicopathological correlations in corticobasal degeneration | Q28245070 | ||
| Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 | Q28253639 | ||
| Dipeptide repeat protein toxicity in frontotemporal lobar degeneration and in motor neurone disease associated with expansions in C9ORF72-a cautionary note | Q48431237 | ||
| Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. | Q48447237 | ||
| Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy | Q48465453 | ||
| Pick's disease. Histological and clinical correlations | Q48610148 | ||
| The temporal variant of frontotemporal dementia | Q48691876 | ||
| Enhanced artistic creativity with temporal lobe degeneration | Q48827603 | ||
| The impact of argyrophilic grain disease on the development of dementia and its relationship to concurrent Alzheimer's disease-related pathology | Q48892551 | ||
| Argyrophilic grain disease presenting with frontotemporal dementia: a neuropsychological and pathological study of an autopsied case with presenile onset | Q48899756 | ||
| The effects of oxytocin on social cognition and behaviour in frontotemporal dementia | Q48938977 | ||
| Increased frequency of argyrophilic grain disease in Alzheimer disease with 4R tau-specific immunohistochemistry | Q48946568 | ||
| Progressive aphasia in a patient with Pick's disease: a neuropsychological, radiologic, and anatomic study | Q49034992 | ||
| Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. | Q50414738 | ||
| Mental and physical activities delay cognitive decline in older persons with dementia. | Q50714198 | ||
| Serotonergic function and treatment of behavioral and psychological symptoms of frontotemporal dementia | Q50994570 | ||
| Memantine in behavioral variant frontotemporal dementia: negative results. | Q51824504 | ||
| Frontal presentation in progressive supranuclear palsy. | Q51900314 | ||
| Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. | Q51967426 | ||
| Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia. | Q51970665 | ||
| A Visual Rating Scale for the Hummingbird Sign with Adjustable Diagnostic Validity. | Q52148845 | ||
| 5' splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10. | Q52535062 | ||
| Regional cerebral blood flow in organic dementia with early onset | Q52744148 | ||
| Treatment options for tauopathies. | Q53326015 | ||
| Ubiquitin immunohistochemistry suggests classic motor neuron disease, motor neuron disease with dementia, and frontotemporal dementia of the motor neuron disease type represent a clinicopathologic spectrum. | Q53661164 | ||
| Wide phenotypic spectrum of the TARDBP gene: homozygosity of A382T mutation in a patient presenting with amyotrophic lateral sclerosis, Parkinson's disease, and frontotemporal lobar degeneration, and in neurologically healthy subject. | Q54416684 | ||
| SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis | Q55671566 | ||
| El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases a | Q55984319 | ||
| Frontotemporal dementia | Q56388056 | ||
| Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups | Q59549757 | ||
| Dietary changes, compulsions and sexual behavior in frontotemporal degeneration | Q71721816 | ||
| Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22 | Q73031723 | ||
| Trans-cellular propagation of Tau aggregation by fibrillar species | Q36003836 | ||
| Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage | Q36017101 | ||
| Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases | Q36083108 | ||
| A Novel Tau Mutation in Exon 12, p.Q336H, Causes Hereditary Pick Disease | Q36167192 | ||
| Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features | Q36198642 | ||
| Tauopathies as clinicopathological entities | Q36326790 | ||
| Mutation in the tau gene in familial multiple system tauopathy with presenile dementia | Q36507684 | ||
| Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival | Q36527176 | ||
| Deep clinical and neuropathological phenotyping of Pick disease | Q36586085 | ||
| Cognition and neuropsychiatry in behavioral variant frontotemporal dementia by disease stage | Q36603831 | ||
| Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17 | Q36637691 | ||
| Plasma neurofilament light chain predicts progression in progressive supranuclear palsy | Q36639639 | ||
| The natural history of temporal variant frontotemporal dementia | Q36647734 | ||
| Criteria for the diagnosis of corticobasal degeneration | Q36661843 | ||
| The enigma of vascular cognitive disorder and vascular dementia | Q36730292 | ||
| Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. | Q36790701 | ||
| Behavioural interventions for enhancing life participation in behavioural variant frontotemporal dementia and primary progressive aphasia | Q36861930 | ||
| Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes | Q36862751 | ||
| Structural anatomy of empathy in neurodegenerative disease | Q36925661 | ||
| Dominant frontotemporal dementia mutations in 140 cases of primary progressive aphasia and speech apraxia | Q36934335 | ||
| Argyrophilic grain disease differs from other tauopathies by lacking tau acetylation. | Q36954430 | ||
| The neuropathology of FTD associated With ALS. | Q37036221 | ||
| A model for management of behavioral symptoms in frontotemporal lobar degeneration | Q37036233 | ||
| Accumulation of dipeptide repeat proteins predates that of TDP-43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene | Q37068280 | ||
| Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial | Q37131376 | ||
| Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN | Q37180625 | ||
| Neurofilament light chain: a biomarker for genetic frontotemporal dementia | Q37208495 | ||
| Tau-based treatment strategies in neurodegenerative diseases | Q37215861 | ||
| Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia | Q37260852 | ||
| Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia | Q37304614 | ||
| Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration | Q37340843 | ||
| Anatomic correlates of stereotypies in frontotemporal lobar degeneration | Q37350593 | ||
| Characterizing radiology reports in patients with frontotemporal dementia | Q37368361 | ||
| Gene expression study on peripheral blood identifies progranulin mutations | Q37411590 | ||
| Globular glial tauopathies (GGT): consensus recommendations | Q37557601 | ||
| Therapy and clinical trials in frontotemporal dementia: past, present, and future | Q37566888 | ||
| Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 | Q28253651 | ||
| FUS pathology in basophilic inclusion body disease | Q28261473 | ||
| The evolution and pathology of frontotemporal dementia | Q28262830 | ||
| Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17 | Q28274687 | ||
| Slowly progressive aphasia without generalized dementia | Q28278856 | ||
| Comparison of family histories in FTLD subtypes and related tauopathies | Q28286447 | ||
| Dissociable intrinsic connectivity networks for salience processing and executive control | Q28290658 | ||
| TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia | Q28294001 | ||
| The neuropathology and clinical phenotype of FTD with progranulin mutations | Q28299352 | ||
| The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier) | Q28485924 | ||
| Selective functional, regional, and neuronal vulnerability in frontotemporal dementia | Q28750210 | ||
| Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria | Q29614410 | ||
| TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis | Q29615597 | ||
| Neurodegenerative tauopathies | Q29619895 | ||
| Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia | Q30486197 | ||
| Phenotypic heterogeneity within a new family with the MAPT p301s mutation | Q31012516 | ||
| Awaji criteria improves the diagnostic sensitivity in amyotrophic lateral sclerosis: A systematic review using individual patient data | Q31099553 | ||
| Functional correlates of musical and visual ability in frontotemporal dementia | Q31794735 | ||
| Asymmetric functional roles of right and left ventromedial prefrontal cortices in social conduct, decision-making, and emotional processing | Q33185350 | ||
| Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration | Q33685317 | ||
| Rest-activity and behavioral disruption in a patient with frontotemporal dementia | Q33690326 | ||
| A case study of an emerging visual artist with frontotemporal lobar degeneration and amyotrophic lateral sclerosis | Q33690396 | ||
| Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. | Q33805339 | ||
| Apathy symptom profile and behavioral associations in frontotemporal dementia vs dementia of Alzheimer type | Q33874226 | ||
| Tau potentiates nerve growth factor-induced mitogen-activated protein kinase signaling and neurite initiation without a requirement for microtubule binding. | Q33911246 | ||
| FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration | Q33922335 | ||
| The many faces of corticobasal degeneration | Q34009887 | ||
| Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update | Q34020227 | ||
| Distinct pathological subtypes of FTLD-FUS. | Q34024578 | ||
| Corticodentatonigral Degeneration With Neuronal Achromasia | Q34053964 | ||
| Patterns of brain atrophy in frontotemporal dementia and semantic dementia | Q34110685 | ||
| Symmetric corticobasal degeneration (S-CBD). | Q34136201 | ||
| Sporadic Pick's disease: a tauopathy characterized by a spectrum of pathological tau isoforms in gray and white matter | Q34138183 | ||
| Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update | Q34143605 | ||
| Editorial: The prevalence and malignancy of Alzheimer disease. A major killer | Q34178758 | ||
| Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia | Q46047796 | ||
| Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy | Q46140676 | ||
| Emotion comprehension in the temporal variant of frontotemporal dementia | Q46153347 | ||
| Emergence of artistic talent in frontotemporal dementia | Q46218099 | ||
| Genetic evidence for the involvement of tau in progressive supranuclear palsy | Q46442862 | ||
| Topiramate may modulate alcohol abuse but not other compulsive behaviors in frontotemporal dementia: case report. | Q46549206 | ||
| The overlap of amyotrophic lateral sclerosis and frontotemporal dementia | Q46924395 | ||
| Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations | Q46986726 | ||
| Vascular dementia: a historical background | Q47248137 | ||
| Familial nature and continuing morbidity of the amyotrophic lateral sclerosis-parkinsonism dementia complex of Guam | Q47332369 | ||
| Early dipeptide repeat pathology in a frontotemporal dementia kindred with C9ORF72 mutation and intellectual disability | Q47548592 | ||
| Alzheimer's disease in the 100 years since Alzheimer's death | Q47918885 | ||
| Motivation of extended behaviors by anterior cingulate cortex | Q48017928 | ||
| Pathologic heterogeneity in clinically diagnosed corticobasal degeneration | Q48111354 | ||
| Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease | Q48115922 | ||
| Early diagnosis of the frontal variant of frontotemporal dementia: how sensitive are standard neuroimaging and neuropsychologic tests? | Q48223140 | ||
| Progressive supranuclear palsy with dementia: cortical pathology. | Q48225828 | ||
| TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations | Q48284829 | ||
| Progressive right frontotemporal degeneration: clinical, neuropsychological and SPECT characteristics. | Q48292513 | ||
| Frontal lobe degeneration of non-Alzheimer type revisited | Q48292633 | ||
| VBM signatures of abnormal eating behaviours in frontotemporal lobar degeneration | Q48302804 | ||
| Vulnerability to neuroleptic side effects in frontotemporal lobar degeneration. | Q48420959 | ||
| Absence of FUS-immunoreactive pathology in frontotemporal dementia linked to chromosome 3 (FTD-3) caused by mutation in the CHMP2B gene | Q48428808 | ||
| The molecular links between TDP-43 dysfunction and neurodegeneration | Q37593727 | ||
| Nonprogressive behavioural frontotemporal dementia: recent developments and clinical implications of the 'bvFTD phenocopy syndrome'. | Q37801816 | ||
| Neuropathological background of phenotypical variability in frontotemporal dementia | Q37879961 | ||
| New potential therapeutic approaches in frontotemporal dementia: oxytocin, vasopressin, and social cognition | Q37880660 | ||
| Frontotemporal dementia: what can the behavioral variant teach us about human brain organization? | Q37889021 | ||
| Clinical phenomenology and neuroimaging correlates in ALS-FTD. | Q37942499 | ||
| Phenotypic signatures of genetic frontotemporal dementia | Q37944092 | ||
| FET proteins in frontotemporal dementia and amyotrophic lateral sclerosis | Q37977235 | ||
| Biochemistry and cell biology of tau protein in neurofibrillary degeneration | Q38023859 | ||
| How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other? | Q38049993 | ||
| Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development | Q38050217 | ||
| The role of TDP-43 in the pathogenesis of ALS and FTLD. | Q38164383 | ||
| Progranulin in neurodegenerative disease | Q38209699 | ||
| Timing and significance of pathological features in C9orf72 expansion-associated frontotemporal dementia | Q38377569 | ||
| Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases | Q38378521 | ||
| Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia | Q38394749 | ||
| Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations | Q38401876 | ||
| Does corticobasal degeneration exist? A clinicopathological re-evaluation | Q38415885 | ||
| Primary progressive aphasia: diagnosis, varieties, evolution. | Q38427052 | ||
| Guilty by suspicion? Criminal behavior in frontotemporal lobar degeneration | Q38449185 | ||
| The differentiation of semantic dementia and frontal lobe dementia (temporal and frontal variants of frontotemporal dementia) from early Alzheimer's disease: a comparative neuropsychological study | Q38450528 | ||
| The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene | Q38493216 | ||
| Genetics of FTLD: overview and what else we can expect from genetic studies | Q38786774 | ||
| Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies | Q38866202 | ||
| The Prevalence and Incidence of Frontotemporal Dementia: a Systematic Review | Q38866379 | ||
| Estimating the number of persons with frontotemporal lobar degeneration in the US population | Q38939262 | ||
| Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis | Q40029964 | ||
| The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts | Q40194429 | ||
| Complex compulsive behaviour in the temporal variant of frontotemporal dementia. | Q40670623 | ||
| Repetitive and compulsive behavior in frontal lobe degenerations | Q40679614 | ||
| Tau complexes with phospholipase C-gamma in situ | Q41042281 | ||
| Neurodegenerative disorders with extensive tau pathology: a comparative study and review | Q41084709 | ||
| Inheritance of frontotemporal dementia | Q41679025 | ||
| Topography of FUS pathology distinguishes late-onset BIBD from aFTLD-U. | Q41903653 | ||
| Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations | Q41942745 | ||
| Tau is a candidate gene for chromosome 17 frontotemporal dementia | Q42456776 | ||
| Pilot study of pharmacological treatment for frontotemporal dementia: risk of donepezil treatment for behavioral and psychological symptoms | Q43461573 | ||
| Clinical and anatomical correlates of apraxia of speech. | Q44438565 | ||
| Efficacy of fluvoxamine as a treatment for behavioral symptoms in frontotemporal lobar degeneration patients | Q44739300 | ||
| Frontotemporal dementia: a randomised, controlled trial with trazodone | Q44922723 | ||
| TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. | Q45927072 | ||
| Stereotypical movements and frontotemporal dementia. | Q45935141 | ||
| 'Limits and current knowledge of Pick's disease: its differential diagnosis'. A translation of the 1957 Delay, Brion, Escourolle article. | Q45942434 | ||
| Eating disturbance in behavioural-variant frontotemporal dementia | Q34185521 | ||
| FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations | Q34209561 | ||
| Survival in frontotemporal dementia | Q34221554 | ||
| PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA. | Q34256347 | ||
| Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease | Q34282454 | ||
| Imaging correlates of pathology in corticobasal syndrome | Q34370058 | ||
| Argyrophilic grain disease mimicking temporal Pick's disease: a clinical, radiological, and pathological study of an autopsy case with a clinical course of 15 years. | Q34373885 | ||
| Of brain and bone: the unusual case of Dr. A. | Q34383946 | ||
| Altered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansion | Q34399242 | ||
| Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors | Q34428922 | ||
| The effects of executive and behavioral dysfunction on the course of ALS. | Q34475318 | ||
| Anatomical correlates of early mutism in progressive nonfluent aphasia | Q34570333 | ||
| Neural networks in frontotemporal dementia--a meta-analysis | Q34586440 | ||
| Early frontotemporal dementia targets neurons unique to apes and humans | Q34594375 | ||
| Neuroimaging in frontotemporal dementia | Q34682550 | ||
| Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop | Q34733901 | ||
| Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia | Q34749217 | ||
| The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease | Q34792591 | ||
| Goals in symptomatic pharmacologic management of frontotemporal lobar degeneration | Q34976729 | ||
| Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. | Q34982074 | ||
| A patient carrying a homozygous p.A382T TARDBP missense mutation shows a syndrome including ALS, extrapyramidal symptoms, and FTD | Q35332219 | ||
| Loss of emotional insight in behavioral variant frontotemporal dementia or "frontal anosodiaphoria". | Q35420844 | ||
| Self awareness and personality change in dementia | Q35487434 | ||
| Behavioral variant frontotemporal dementia with corticobasal degeneration pathology: phenotypic comparison to bvFTD with Pick's disease | Q35523746 | ||
| Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD. | Q35609244 | ||
| Criminal behavior in frontotemporal dementia and Alzheimer disease | Q35609899 | ||
| Neuroanatomical correlates of behavioural disorders in dementia | Q35677177 | ||
| Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis. | Q35686186 | ||
| Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease | Q35752114 | ||
| The many faces of tau | Q35870359 | ||
| Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. | Q35889804 | ||
| TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions | Q35928153 | ||
| Voxel-based morphometry in patients with obsessive-compulsive behaviors in behavioral variant frontotemporal dementia | Q35957307 | ||
| P433 | issue | 2 | |
| P921 | main subject | frontotemporal dementia | Q18592 |
| P304 | page(s) | 339-374 | |
| P577 | publication date | 2017-05-01 | |
| P1433 | published in | Neurologic Clinics | Q15756619 |
| P1476 | title | Frontotemporal Dementia | |
| P478 | volume | 35 |
| Q92198288 | Astroglial connexins and cognition: memory formation or deterioration? |
| Q55102548 | Auto-antibodies against P/Q- and N-type voltage-dependent calcium channels mimicking frontotemporal dementia. |
| Q92000775 | C9ORF72-ALS/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo |
| Q91710094 | CNS-Derived Blood Exosomes as a Promising Source of Biomarkers: Opportunities and Challenges |
| Q90118766 | Cerebrospinal fluid biomarkers and cognitive status in differential diagnosis of frontotemporal dementia and Alzheimer's disease |
| Q64298179 | Dementia spectrum disorders: lessons learnt from decades with PET research |
| Q90702725 | Diverse, evolving conformer populations drive distinct phenotypes in frontotemporal lobar degeneration caused by the same MAPT-P301L mutation |
| Q55261436 | Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma. |
| Q91828425 | Empathy In Neurodegenerative Diseases: A Systematic Review |
| Q90265030 | Exploration Deficits Under Ecological Conditions as a Marker of Apathy in Frontotemporal Dementia |
| Q92215030 | Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia |
| Q99711757 | Genetics of dementia: insights from Latin America |
| Q47218394 | Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies |
| Q90604332 | Inherited and Sporadic Amyotrophic Lateral Sclerosis and Fronto-Temporal Lobar Degenerations arising from Pathological Condensates of Phase Separating Proteins |
| Q88577959 | Insights into C9ORF72-Related ALS/FTD from Drosophila and iPSC Models |
| Q93332882 | Long-Term Non-Invasive Treatment via Intranasal Administration of Nerve Growth Factor Protects the Human Brain in Frontotemporal Dementia associated with Corticobasal Syndrome: A Pilot Study |
| Q52344625 | Neuroimmune Tau Mechanisms: Their Role in the Progression of Neuronal Degeneration. |
| Q90399950 | Neuroinflammation as a Common Feature of Neurodegenerative Disorders |
| Q90282904 | Partial inhibition of the overactivated Ku80-dependent DNA repair pathway rescues neurodegeneration in C9ORF72-ALS/FTD |
| Q64983354 | Pathogenesis of Frontotemporal Lobar Degeneration: Insights From Loss of Function Theory and Early Involvement of the Caudate Nucleus. |
| Q64119235 | Precision Medicine for Frontotemporal Dementia |
| Q64899263 | Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD. |
| Q97692983 | Remodeling without destruction: non-proteolytic ubiquitin chains in neural function and brain disorders |
| Q53836192 | Repetitive transcranial magnetic stimulation for the treatment of cognitive impairment in frontotemporal dementia: an open-label pilot study. |
| Q91687445 | Resting State Dynamic Functional Connectivity in Neurodegenerative Conditions: A Review of Magnetic Resonance Imaging Findings |
| Q90613713 | Role of Fluid Biomarkers and PET Imaging in Early Diagnosis and its Clinical Implication in the Management of Alzheimer's Disease |
| Q89208306 | Selective targeting of 3 repeat Tau with brain penetrating single chain antibodies for the treatment of neurodegenerative disorders |
| Q47926474 | Small-molecule PET Tracers for Imaging Proteinopathies |
| Q55517106 | TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis. |
| Q64054848 | Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models |
| Q96136950 | The Link Between Rheumatoid Arthritis and Dementia: A Review |
| Q47257826 | The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease |
| Q91971334 | The Role of TDP-43 in Military-Relevant TBI and Chronic Neurodegeneration |
| Q91558625 | Transcription elongation factor AFF2/FMR2 regulates expression of expanded GGGGCC repeat-containing C9ORF72 allele in ALS/FTD |
Search more.